BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17761351)

  • 1. Inhibition of in vitro tumor cell proliferation by cytokines induced by combinations of TLR or TLR and TCR agonists.
    Ghosh TK; Mickelson DJ; Lipson KE; Alkan SS
    Int Immunopharmacol; 2007 Nov; 7(11):1471-82. PubMed ID: 17761351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
    Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
    Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.
    Ramakers BP; Riksen NP; Rongen GA; van der Hoeven JG; Smits P; Pickkers P
    Cytokine; 2006 Jul; 35(1-2):95-9. PubMed ID: 16963274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.
    Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS
    Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.
    Liu S; Riley J; Rosenberg S; Parkhurst M
    J Immunother; 2006; 29(3):284-93. PubMed ID: 16699371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Toll-like receptors (TLR) and responsiveness to TLR agonists by polarized mouse uterine epithelial cells in culture.
    Soboll G; Shen L; Wira CR
    Biol Reprod; 2006 Jul; 75(1):131-9. PubMed ID: 16510838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer.
    Paul S; Regulier E; Poitevin Y; Hormann H; Acres RB
    Cancer Immunol Immunother; 2002 Dec; 51(11-12):645-54. PubMed ID: 12439610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations.
    van den Biggelaar AH; Prescott SL; Roponen M; Nadal-Sims MA; Devitt CJ; Phuanukoonnon S; Pomat W; Tulic MK; Lehmann D; Siba PM; Richmond PC; Holt PG
    J Allergy Clin Immunol; 2009 Sep; 124(3):544-50, 550.e1-2. PubMed ID: 19500827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D; Zepp F; Meyer CU
    Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
    Smits EL; Cools N; Lion E; Van Camp K; Ponsaerts P; Berneman ZN; Van Tendeloo VF
    Cancer Immunol Immunother; 2010 Jan; 59(1):35-46. PubMed ID: 19449004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors.
    Weaver LK; Pioli PA; Wardwell K; Vogel SN; Guyre PM
    J Leukoc Biol; 2007 Mar; 81(3):663-71. PubMed ID: 17164428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
    Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands.
    Alsaleh G; Messer L; Semaan N; Boulanger N; Gottenberg JE; Sibilia J; Wachsmann D
    Arthritis Rheum; 2007 Oct; 56(10):3202-14. PubMed ID: 17907168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
    de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
    J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
    Roelofs MF; Wenink MH; Brentano F; Abdollahi-Roodsaz S; Oppers-Walgreen B; Barrera P; van Riel PL; Joosten LA; Kyburz D; van den Berg WB; Radstake TR
    Ann Rheum Dis; 2009 Sep; 68(9):1486-93. PubMed ID: 18765427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
    Dil N; Marshall AJ
    Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.
    Kikkert R; de Groot ER; Aarden LA
    J Immunol Methods; 2008 Jul; 336(1):45-55. PubMed ID: 18456276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell responses in fresh and cryopreserved peripheral blood mononuclear cells: kinetics of cell viability, cellular subsets, proliferation, and cytokine production.
    Jeurink PV; Vissers YM; Rappard B; Savelkoul HF
    Cryobiology; 2008 Oct; 57(2):91-103. PubMed ID: 18593572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.